top of page
DALL·E 2024-12-03 10.24_edited.jpg

The PURPOSE Study

Right Dose. Right Treatment. Right Future.

Join us in funding the Psilocybin Use: Recreational and Medical Patterns, Outcomes, and Effects (PURPOSE) Study, a groundbreaking research survey study aiming to answer key questions about psilocybin.

Psilocybin, a naturally occurring psychedelic compound, has been praised for its potential therapeutic benefits. However, much remains unknown.

 

Clinika Research, in collaboration with Canna Research Foundation and Psychedelist, is launching The PURPOSE Study, designed to fill these knowledge gaps by surveying 250-500 psilocybin users, anonymously.

​​

What We Aim to Discover:

  • Who benefits most from psilocybin and why

  • Optimal dosing strategies for various therapeutic outcomes

  • How psilocybin impacts reliance on traditional medications

 

This study is crucial for:

  • Advancing psilocybin research and ensuring safe, effective treatments for mental health and wellness 

  • Destigmatizing psilocybin as medical therapy

  • Creating educational materials for consumers, therapists, industry stakeholders, and the medical field

Support the Study

In order to conduct The PURPOSE Study, we are looking to you help us fund this crucially needed research to bridge the gap between anecdotal evidence and clinical research. Your donation will help us achieve critical insights and improve lives. Donations are tax-deductible through our partnership with Canna Research Foundation, a 501(c)(3) public charity.

 

No Contribution is Too Small!

Every dollar brings us closer to answering the essential questions about psilocybin's therapeutic potential.

​

Sponsorship Levels

We are offering special incentives for our generous sponsors:​

BRONZE

$250+

Acknowledgement as a sponsor in publications and presentations.

SILVER

$1,000+

Bronze benefits plus a 70% discount on an annual Psychedelist.com membership.

GOLD

$5,000+

Silver benefits plus prominent recognition on the research team websites (Canna Research Foundation, Psychedelist, and Clinika Research) and on materials, webinar invites, and acknowledgment in final reports/publications.

Why this Study Matters

Psilocybin research is on the cutting edge of mental health and medicinal therapy, but we need your help to move the field forward.

 

The PURPOSE Study will provide actionable insights for:

  • Medical professionals seeking effective treatments

  • Patients looking for alternative therapies

  • Researchers and industry leaders driving innovation in psychedelics

Your support can transform lives and revolutionize medicine. Let’s start with PURPOSE.​

  • What is The PURPOSE Study?
    The PURPOSE Study, or Psilocybin Use: Recreational and Medical Patterns, Outcomes, and Effects, is a groundbreaking research project that seeks to understand how psilocybin is used, its therapeutic benefits, and how it impacts reliance on traditional medications. By surveying 250-500 anonymous psilocybin users, this study aims to bridge the gap in knowledge about this promising compound.
  • How will my donation be used?
    Your contribution will directly support: Participant recruitment and data collection. Statistical analysis and publication of results. Dissemination of findings to medical professionals and the public. Donations are tax-deductible, and every dollar helps us move closer to unlocking psilocybin's potential.
  • Why is this study important?
    Psilocybin has shown promise in treating conditions like depression, anxiety, and PTSD. However, detailed information about its real-world use, safety, and effectiveness remains limited. The PURPOSE Study will provide critical insights that can guide safe and effective applications in both medical and recreational contexts.
  • Are my donations tax-deductible?
    Yes! The Canna Research Foundation operates under a fiscal sponsorship with the Players Philanthropy Fund, a 501(c)(3) public charity. Donations are tax-deductible to the fullest extent of the law.
  • What are the sponsorship levels and what do they include?
    We offer three levels of sponsorship: Bronze ($250+): Name on our website, exclusive updates. Silver ($1,000+): Bronze plus discounted Psychedelist.com listings. Gold ($5,000+): Silver plus prominent recognition on our site and materials, webinar invites, and acknowledgment in final reports.
  • What makes psilocybin research different from other studies?
    Psilocybin research is at the cutting edge of mental health and wellness innovation. Unlike many other studies, this research focuses on real-world use patterns, comparing micro-dosing with guided therapy, and assessing its ability to reduce dependence on traditional medications.
  • Can I participate in the study?
    The study is anonymous and open to psilocybin users who meet the inclusion criteria. Specific details about participation will be shared soon on our website. If you're interested, keep an eye out for updates or reach out to us.
  • How can I help if I can’t donate?
    Even if you can’t contribute financially, you can support us by: Sharing our campaign with friends and family. Following and promoting us on social media. Advocating for psilocybin research in your community.
  • When will the study results be available?
    Once we complete data collection and analysis, results will be published in peer-reviewed journals and shared on our website. Sponsors will receive exclusive early updates on our findings.
  • How do I contact the research team?
    You can reach us at: Email: Info@ClinikaResearch.com Phone: 303.345.8867
bottom of page